← Back to Search

Personalized, Transdiagnostic Assessments for Mental Illness

N/A
Waitlist Available
Led By Michael K Owens
Research Sponsored by Introspect Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights

Study Summary

Personalized, Transdiagnostic Approach to Preventative Mental Health

Eligible Conditions
  • Mental Illness
  • Mental Health
  • Delivery of Health Care
  • Self-Assessment
  • Mental Health Diagnosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Assessment Questions Scored
Completed Assessments Scored
Self-Report Adherence Rate
Secondary outcome measures
Assessment Completion Rate
Response Time
Time per Assessment Question

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Personalized, Transdiagnostic AssessmentsExperimental Treatment1 Intervention
One or more times per day, participants in the Experimental Arm will be presented with a variable-length assessment based on the personalization algorithm. The assessment will include a dynamic number of questions based on personalized relevancy, engagement level, and assessment completion metrics. Questions are scored immediately upon submission, regardless of how many questions are answered. As questions are scored, the personalization algorithm takes the previous responses and response times into consideration when determining what and when to ask additional questions.
Group II: Monotopic AssessmentsActive Control1 Intervention
Once daily, participants in the Control Arm will be presented with the standard of care mental health surveillance assessments identified as relevant upon intake. The assessments will be scored in totality or not at all and have a fixed, predefined number of questions. No personalization of assessment will take place.

Find a Location

Who is running the clinical trial?

Introspect HealthLead Sponsor
Anne M Huffman, PhDStudy DirectorCalifornia Institute of Integral Studies
Michael K OwensPrincipal InvestigatorIntrospect Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~8 spots leftby May 2025